Skip to main content

Advertisement

SpringerLink
Log in

HCV load as a possible prognostic factor in patients with HCV-related DLBCL

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Anderson LA, Pfeiffer R, Warren JL et al (2008) Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomark Prev 17:3069–3075

    Article  Google Scholar 

  2. de Sanjose S, Benavente Y, Vajdic CM et al (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6:451–458

    Article  PubMed  PubMed Central  Google Scholar 

  3. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013) Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 59:169–177

    Article  CAS  PubMed  Google Scholar 

  4. Chen YY, Huang CE, Liang FW et al (2015) Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index. Cancer Epidemiol 39:382–387

    Article  PubMed  Google Scholar 

  5. Merli M, Visco C, Spina M et al (2014) Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica 99:489–496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Park BB, Kim JS, Lee YY et al (2008) Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma. Leuk Lymphoma 49:88–94

    Article  PubMed  Google Scholar 

  7. Besson C, Canioni D, Lepage E et al (2006) Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d’Etude des Lymphomes de l’Adulte programs. J Clin Oncol 24:953–960

    Article  PubMed  Google Scholar 

  8. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068

    Article  PubMed  PubMed Central  Google Scholar 

  9. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31:1860–1861

    CAS  PubMed  Google Scholar 

  10. Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  CAS  PubMed  Google Scholar 

  11. Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579–586

    Article  PubMed  Google Scholar 

  12. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345:41–52

    Article  CAS  PubMed  Google Scholar 

  13. Chung RT, Baumert TF (2014) Curing chronic hepatitis C—the arc of a medical triumph. N Engl J Med 370:1576–1578

    Article  CAS  PubMed  Google Scholar 

  14. Torres HA, Mahale P (2015) Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization. Liver Int 35:1661–1664

    Article  PubMed  Google Scholar 

  15. Iannitto E, Ammatuna E, Tripodo C et al (2004) Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment. Hematol J 5:530–533

    Article  CAS  PubMed  Google Scholar 

  16. Pellicelli AM, Marignani M, Zoli V et al (2011) Hepatitis C virus-related B cell subtypes in non Hodgkin’s lymphoma. World J Hepatol 3:278–284

    Article  PubMed  PubMed Central  Google Scholar 

  17. Tamori A, Enomoto M, Kawada N (2016) Recent advances in antiviral therapy for chronic hepatitis C. Mediat Inflamm 2016:6841628

    Article  Google Scholar 

  18. Carrier P, Jaccard A, Jacques J et al (2015) HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents. Liver Int 35:2222–2227

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany

    Xiang Zhou, Katharina Lisenko, Nicola Lehners, Juliane Brandt, Martin Cremer, Anthony Dick Ho & Mathias Witzens-Harig

  2. Institute of Pathology, Heidelberg University, Heidelberg, Germany

    Mark Kriegsmann

Authors
  1. Xiang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katharina Lisenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicola Lehners
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juliane Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martin Cremer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark Kriegsmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anthony Dick Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mathias Witzens-Harig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiang Zhou.

Ethics declarations

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 [5].

Conflict of interest

The authors declare that they have no conflicts of interest.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, X., Lisenko, K., Lehners, N. et al. HCV load as a possible prognostic factor in patients with HCV-related DLBCL. Ann Hematol 97, 351–354 (2018). https://doi.org/10.1007/s00277-017-3124-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3124-5

Search

Navigation